HIV-1 Integrase Inhibitors: An Emerging Clinical Reality

Author： Dayam Raveendra Al-Mawsawi Laith Q. Neamati Nouri

ISSN： 1174-5886

Source： Drugs in R&D, Vol.8, Iss.3, 2007-01, pp. : 155-168

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of HIV-1 Reverse Transcriptase and Integrase: Classical and Emerging Therapeutical Approaches

Current Pharmaceutical Design, Vol. 8, Iss. 8, 2002-04 ,pp. : 595-614

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-infectives Clinical progress of HIV-1 integrase inhibitors

By Al-Mawsawi Laith Q Al-Safi Rasha I Neamati Nouri

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 2, 2008-06 ,pp. : 213-225

Informa Healthcare

Access to resources Recommend Favorite

HIV-1 Integrase Inhibitors: A Decade of Research and Two Drugs in Clinical Trial

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 10, 2004-01 ,pp. : 1059-1077

Bentham Science Publishers

Access to resources Recommend Favorite

Computational Studies of HIV-1 Integrase and its Inhibitors

Current Computer - Aided Drug Design, Vol. 3, Iss. 3, 2007-09 ,pp. : 160-190

Bentham Science Publishers

Access to resources Recommend Favorite

Dipyrimidine-based inhibitors of HIV-1 integrase

By Neamati Nouri

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 289-292

Informa Healthcare

Access to resources Recommend Favorite